Shares of Gilead Sciences Inc. GILD slid 3.09% to $103.25 Thursday, on what proved to be an all-around favorable trading ...

Gilead Sciences agreed to pay $202 million to the U.S. government and various states to settle claims it used speaker ...

The biotech downturn claims another victim, but this deal structure offers a glimmer of hope for Kronos investors. Local ...

Gilead Sciences has agreed to pay $202 million to resolve allegations that it violated the Anti-Kickback Statute by using speaker programs to incentivize physicians to prescribe HIV medications.

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

Pharmaceutical firm Gilead has admitted paying hundreds of thousands of dollars in illegal kickbacks to US doctors between ...

Over the years, a host of large drugmakers have inked settlements with the federal authorities to resolve allegations that ...

Shares of Gilead Sciences Inc. GILD rallied 2.24% to $106.54 Wednesday, on what proved to be an all-around favorable trading ...

The company paid to settle allegations of paying kickbacks to doctors in exchange for prescribing several of its HIV ...

Drivers traveling west of the interstate should detour to I-77 South, then take WT Harris Boulevard back to I-77 North. For ...

[CNBC] Gilead Sciences agrees to pay $202 million to settle claims of kickbacks to doctors for HIV drug prescriptions ...

Those questions aside, our most pressing pondering at the moment relates to the ever-slippery Serena Joy. Back in a position ...